News Focus
News Focus
icon url

nidan7500

05/02/19 6:25 PM

#191404 RE: falconer66a #191401

Falconer, I defer to your insights on what and how much is REALLY known in the broader CNS academic-business community. How much CNS disease denial do you think we are going to have to deal with? Is anticipation of that what we are seeing in the plan to replicate PDD in AUS? Are academia and BP really that isolated? One gets the impression there are going to be a lot of red faces around when it all sinks in. Lets face it, HH and Dr.M. are about to slam dunk the biggest prize ever.
icon url

tradeherpete

05/02/19 6:35 PM

#191408 RE: falconer66a #191401

I guess being subjected to the rodents on this board has skewed my view on our place in the CNS universe. Scientifically Anavex has been in the center in our opinion while the uninformed still maintain skepticism. OK. The NY Times is for those that don’t have time or interest in searching for themselves and need someone to spoon feed them. We shouldn’t really need to care about them, nor should Anavex.

imo

edit; we'll prolly be back at 2.50 tomorrow! Which would prove your point. We shall see!
icon url

georgejjl

05/03/19 8:52 AM

#191458 RE: falconer66a #191401

Activation of sigma-1 receptor chaperone in the treatment of neuropsychiatric diseases and its clinical implication



https://www.sciencedirect.com/science/article/pii/S1347861314000176

Good luck and GOD bless,